
Abra Bound 100mg Injection
Salt Composition: Albumin Bound Paclitaxel
Expiry Date: 01/2028
Inclusive of all taxes
1 injection
About The Product
Breast Cancer
Albumin Bound Paclitaxel 100mg injection contain Paclitaxel that is a taxoid antineoplastic agent indicated as first-line and subsequent therapy. It is a novel antimicrotubule agent. It is an anticancer medicine used to treat certain types of cancers including Breast Cancer, Lung Cancer, and Pancreatic Cancer. Abra-bound is available in the form of an injection in the strength of 100 mg. This injection is given into the vein of the patient, by a medical practitioner and is prescribed in combination with other anti-cancer drugs for better efficac
Side Effects
Side effects are undesirable symptoms that can result from any medical treatment. Like any other medicine, Paclitaxel 100mg injection also causes some adverse impact on the body, most of which resolve without any medical attention.
Some common side effects include:
- Diarrhea
- Nausea
- Fever
- Chills
- Vomiting
- Chest pain
- Skin rash
- Itching
- Allergic reaction
- Cough
- Constipation
- Seek medical attention in case of any unusual or severe side effects immediately.
How To Use
- It is advisable to not self-administer this injection.
- Your healthcare provider will give you Paclitaxel 100mg injection according to your medical condition.
- Duartion of the treatment decided by doctor according to patient's health condition and other factors.
- In case you experience symptoms of overdose, immediately call your doctor or any other medical emergency helpline.
Safety Advice
Missed Doses
- Initially, it is advisable to not miss a dose.
- However, if such a case happens, make sure to consult your healthcare provider to schedule an appointment for the same or guide you further.
FAQs
Paclitaxel 100mg injection is an anti-cancer medication, prescribed for the treatment of Breast Cancer, Lung Cancer, and Pancreatic Cancer.
Reference
- http://accessdata.fda.gov/drugsatfda_docs/label/2020/021660s047lbl.pdf
- KATO, Y., WATANABE, K., NAKAMURA, M., HOSOKAWA, T., HAYAKAWA, E., & ITO, K. (1993). Blood Cleatance and Tissue Distribution of Various Formulations of α-Tocopherol Injection after Intravenous Administration. Chemical and pharmaceutical bulletin, 41(3), 599-604.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2720743/
- Debs, R. J., Straubinger, R. M., Brunette, E. N., Lin, J. M., Lin, E. J., Montgomery, A. B., ... & Papahadjopoulos, D. P. (1987). Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes. American Review of Respiratory Disease, 135(3), 731-737.
- https://www.pbs.gov.au/info/industry/listing/elements/pbac-meetings/psd/2014-03/paclitaxel-nanoparticle-albumin-bound-psd-03-2014
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
